Status:
COMPLETED
Evaluation of the Impact of a Multidimensional ICT Intervention on the Quality of Life of Breast Cancer Survivors
Lead Sponsor:
Fundacion Clinic per a la Recerca Biomédica
Collaborating Sponsors:
Fundacion iSYS, internet, salud y sociedad
Conditions:
Breast Cancer
Breast Neoplasms
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
mACMA is a pilot study that is developed for breast cancer survivors of the Hospital Clinic of Barcelona. The objective of this study is to evaluate the progress in quality of life through the introdu...
Eligibility Criteria
Inclusion
- Previous diagnostic of breast cancer
- Free of disease at the time of randomization
- Signed consent form
- Possession of a smartphone and ability to use smartphone applications
- Patients belonging to the ACMA group o being treated at Hospital Clínic
- Without diagnosis of neurodegenerative disorders that prevent participation in the study
Exclusion
- Acute process of cancer at the moment of recruitment
- Active treatment for cancer (chemotherapy, radiotherapy)
- Comorbidities such as heart failure NYHA class 4, COPD,...
- Inability to give informed consent
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05401643
Start Date
November 1 2020
End Date
June 30 2023
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínic
Barcelona, Catalonia, Spain, 08036